The New York Times has cut ties with a freelancer after the paper discovered he used AI to help write a book review that inadvertently incorporated elements of a Guardian review on the same title. A ...

Colson Montgomery's launch angle consistency bodes well for his ability to improve his batting average returns. Icon Sportswire / Getty Images Diving into the standard deviation of launch angle (sdLA) ...

Chandra Steele has been writing about tech for the entirety of her journalism career. She loves making tough topics easy to understand. Before joining Android Police, Chandra was senior features ...

The goal should be purposeful integration: using records to improve context for education, navigation, and appropriate escalation—without presenting the tool as a substitute for professional judgment.

Android‘s Find Hub now lets you share your lost luggage’s precise location directly with airlines. The feature arrives just as holiday travel hits its peak and bags inevitably go missing. You generate ...

As the attacks continue, Iranians have turned to Space X’s satellite internet technology — including one of the country’s most notorious hacker crews, which is claiming retaliatory cyberattacks ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

When the score got out of hand, coach Kim Mulkey started experimenting. She played four guards. Then she played five. She even defied her nature and threw out a zone defense — something she hardly ...

This week, Palantir announced on X it’s relocating its headquarters to Miami. Plus, a look at the controversy around Ring's Search Party feature. But first, an update to Google's AI search summaries.

In case you had any doubt, Elon Musk’s X has an algorithm that favors conservative content posted by political activists over liberal content or posts by traditional news media accounts, according to ...

— Finding Hope for FRRS1L plans to initiate clinical trial using TfR1 CapX gene therapy in the second half of 2026, pending regulatory review — FORT COLLINS, Colo. and NEW YORK, Feb. 18, 2026 ...